{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:53:40Z","timestamp":1787169220297,"version":"build-2736575974"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>This special article synthesizes transformative insights from a recent international neonatal cell therapy symposium (held in Noosa, Australia) where leading experts convened to explore regenerative solutions for serious perinatal and neonatal conditions. The discussions highlighted pioneering cell-based therapies targeting preterm brain injury, bronchopulmonary dysplasia, fetal growth restriction, hypoplastic left heart syndrome and congenital diaphragmatic hernia; neonatal conditions that present both neonatal challenges and long-term morbidities, demanding innovation beyond conventional medical, surgical and supportive care. Advances in regenerative medicine, particularly those leveraging umbilical cord blood\u2013derived cells, mesenchymal stromal cells from various sources, amniotic fluid and human amnion epithelial derived cells and extracellular vesicles, are redefining therapeutic possibilities through paracrine signaling, immunomodulation, and tissue repair to counteract shared mechanisms of inflammation, oxidative stress, apoptosis, and impaired regeneration. This article integrates the symposium\u2019s key clinical and translational perspectives, emphasizing system-specific developments across cardiovascular, pulmonary, neurological, and systemic domains, with a particular focus on scalable production strategies, and the importance of multidisciplinary collaboration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Synthesizes global evidence from preclinical and clinical studies to define the current translational trajectory of cell therapies across major neonatal conditions.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Highlights integrative frameworks combining advanced preclinical modeling, clinical trials, scalable manufacturing and stakeholder collaboration to accelerate translation in neonatal regenerative medicine.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05007-2","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:07:15Z","timestamp":1777936035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progress in cell therapies for neonatal conditions: Proceedings of the Third Neonatal Cell Therapies Symposium (2025)"],"prefix":"10.1038","author":[{"given":"Abdul","family":"Razak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison C. B.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sinistaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Soon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Zani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishmael M.","family":"Inocencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi","family":"Fleiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gressens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Messino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Tribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-4182","authenticated-orcid":false,"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"5007_CR1","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1542\/neo.26-5-011","volume":"26","author":"A Razak","year":"2025","unstructured":"Razak, A. & Malhotra, A. Potential applications of umbilical cord blood-derived cells in neonatal diseases. Neoreviews 26, e297\u2013e306 (2025).","journal-title":"Neoreviews"},{"key":"5007_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2025.106369","volume":"210","author":"A Razak","year":"2025","unstructured":"Razak, A. et al. Cord blood-derived cell therapies for preterm brain injury. Early Hum. Dev. 210, 106369 (2025).","journal-title":"Early Hum. Dev."},{"key":"5007_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1056\/NEJMra2303347","volume":"389","author":"TE Inder","year":"2023","unstructured":"Inder, T. E., Volpe, J. J. & Anderson, P. J. Defining the neurologic consequences of preterm birth. N. Engl. J. Med. 389, 441\u2013453 (2023).","journal-title":"N. Engl. J. Med."},{"key":"5007_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1159\/000537801","volume":"121","author":"A Razak","year":"2024","unstructured":"Razak, A. et al. Temporal trends in severe brain injury and associated outcomes in very preterm infants. Neonatology 121, 440\u2013449 (2024).","journal-title":"Neonatology"},{"key":"5007_CR5","doi-asserted-by":"publisher","first-page":"e237473","DOI":"10.1001\/jamanetworkopen.2023.7473","volume":"6","author":"A Razak","year":"2023","unstructured":"Razak, A., Patel, W., Durrani, N. U. R. & Pullattayil, A. K. Interventions to reduce severe brain injury risk in preterm neonates: a systematic review and meta-analysis. JAMA Netw. Open 6, e237473 (2023).","journal-title":"JAMA Netw. Open"},{"key":"5007_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/stcltm\/szad048","volume":"12","author":"A Razak","year":"2023","unstructured":"Razak, A. et al. Allogeneic cell therapy applications in neonates: a systematic review. Stem Cells Transl. Med. 12, 651\u2013664 (2023).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR7","first-page":"Cd013201","volume":"2","author":"O Romantsik","year":"2023","unstructured":"Romantsik, O. et al. Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants. Cochrane Database Syst. Rev. 2, Cd013201 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"5007_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1089-5","volume":"15","author":"CA McDonald","year":"2018","unstructured":"McDonald, C. A. et al. Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury. J. Neuroinflamm. 15, 47 (2018).","journal-title":"J. Neuroinflamm."},{"key":"5007_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41390-019-0366-z","volume":"86","author":"MCB Paton","year":"2019","unstructured":"Paton, M. C. B. et al. Umbilical cord blood versus mesenchymal stem cells for inflammation-induced preterm brain injury in fetal sheep. Pediatr. Res. 86, 165\u2013173 (2019).","journal-title":"Pediatr. Res."},{"key":"5007_CR10","doi-asserted-by":"publisher","first-page":"105492","DOI":"10.1016\/j.ebiom.2024.105492","volume":"111","author":"L Zhou","year":"2025","unstructured":"Zhou, L. et al. Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (cord-safe study). EBioMedicine 111, 105492 (2025).","journal-title":"EBioMedicine"},{"key":"5007_CR11","doi-asserted-by":"publisher","first-page":"e2521158","DOI":"10.1001\/jamanetworkopen.2025.21158","volume":"8","author":"L Zhou","year":"2025","unstructured":"Zhou, L. et al. Early neurodevelopment of extremely preterm infants administered autologous cord blood cell therapy: secondary analysis of a nonrandomized clinical trial. JAMA Netw. Open 8, e2521158 (2025).","journal-title":"JAMA Netw. Open"},{"key":"5007_CR12","unstructured":"Malhotra, A. Autologous Cord Blood-Derived Cell Therapy for Extremely Preterm Infants: An International, Multicentre Randomised Controlled Trial, https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12624000968572 (2024)."},{"key":"5007_CR13","doi-asserted-by":"publisher","first-page":"e100389","DOI":"10.1136\/bmjopen-2025-100389","volume":"15","author":"A Razak","year":"2025","unstructured":"Razak, A. et al. Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (allo trial): a phase-1 trial protocol. BMJ Open 15, e100389 (2025).","journal-title":"BMJ Open"},{"key":"5007_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13287-024-03830-0","volume":"15","author":"TR Penny","year":"2024","unstructured":"Penny, T. R., Jenkin, G., Miller, S. L. & McDonald, C. A. Umbilical cord blood derived cell expansion: a potential neuroprotective therapy. Stem Cell Res. Ther. 15, 234 (2024).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/STROKEAHA.112.679092","volume":"44","author":"SY Ahn","year":"2013","unstructured":"Ahn, S. Y. et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke 44, 497\u2013504 (2013).","journal-title":"Stroke"},{"key":"5007_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3727\/096368915X689640","volume":"25","author":"WS Park","year":"2016","unstructured":"Park, W. S. et al. Optimal timing of mesenchymal stem cell therapy for neonatal intraventricular hemorrhage. Cell Transpl. 25, 1131\u20131144 (2016).","journal-title":"Cell Transpl."},{"key":"5007_CR17","doi-asserted-by":"publisher","first-page":"e0132919","DOI":"10.1371\/journal.pone.0132919","volume":"10","author":"SY Ahn","year":"2015","unstructured":"Ahn, S. Y. et al. Optimal route for mesenchymal stem cells transplantation after severe intraventricular hemorrhage in newborn rats. PLoS One 10, e0132919 (2015).","journal-title":"PLoS One"},{"key":"5007_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/sctm.17-0219","volume":"7","author":"SY Ahn","year":"2018","unstructured":"Ahn, S. Y., Chang, Y. S., Sung, S. I. & Park, W. S. Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial. Stem Cells Transl. Med. 7, 847\u2013856 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/dmcn.15325","volume":"64","author":"JM Sun","year":"2022","unstructured":"Sun, J. M. et al. Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: an open-label, randomized trial. Dev. Med. Child Neurol. 64, 1477\u20131486 (2022).","journal-title":"Dev. Med. Child Neurol."},{"key":"5007_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98504-z","volume":"15","author":"K Wada","year":"2025","unstructured":"Wada, K. et al. Combined treatment with mesenchymal stem cells and therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy: a phase 1\/2 randomized trial. Sci. Rep. 15, 16302 (2025).","journal-title":"Sci. Rep."},{"key":"5007_CR21","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1161\/STROKEAHA.125.050786","volume":"56","author":"N Wagenaar","year":"2025","unstructured":"Wagenaar, N. et al. Perinatal arterial stroke treated with stromal cells intranasally: 2-year safety and neurodevelopment. Stroke 56, 2410\u20132418 (2025).","journal-title":"Stroke"},{"key":"5007_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00983-y","volume":"13","author":"E Pauls","year":"2021","unstructured":"Pauls, E. et al. Identification and drug-induced reversion of molecular signatures of alzheimer\u2019s disease onset and progression in App(Nl-G-F), App(Nl-F), and 3xtg-Ad mouse models. Genome Med. 13, 168 (2021).","journal-title":"Genome Med."},{"key":"5007_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1017\/S204017441700037X","volume":"8","author":"BJ Allison","year":"2017","unstructured":"Allison, B. J. et al. Does growth restriction increase the vulnerability to acute ventilation-induced brain injury in newborn lambs? Implications for future health and disease. J. Dev. Orig. Health Dis. 8, 556\u2013565 (2017).","journal-title":"J. Dev. Orig. Health Dis."},{"key":"5007_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.904144","volume":"13","author":"KY Chan","year":"2022","unstructured":"Chan, K. Y. et al. Investigating pathways of ventilation induced brain injury on cerebral white matter inflammation and injury after 24 h in preterm lambs. Front Physiol. 13, 904144 (2022).","journal-title":"Front Physiol."},{"key":"5007_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41390-023-02911-9","volume":"95","author":"PC Papagianis","year":"2024","unstructured":"Papagianis, P. C. et al. Postnatal steroids as lung protective and anti-inflammatory in preterm lambs exposed to antenatal inflammation. Pediatr. Res. 95, 931\u2013940 (2024).","journal-title":"Pediatr. Res."},{"key":"5007_CR26","doi-asserted-by":"crossref","unstructured":"Yates, N. J. et al. Ex vivo MRI analytical methods and brain pathology in preterm lambs treated with postnatal dexamethasone (\u2020). Brain Sci. 10, 211 (2020).","DOI":"10.3390\/brainsci10040211"},{"key":"5007_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100458","volume":"23","author":"L Klein","year":"2022","unstructured":"Klein, L. et al. Prenatal administration of multipotent adult progenitor cells modulates the systemic and cerebral immune response in an ovine model of chorioamnionitis. Brain Behav. Immun. Health 23, 100458 (2022).","journal-title":"Brain Behav. Immun. Health"},{"key":"5007_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.reth.2024.03.014","volume":"27","author":"SML Neuen","year":"2024","unstructured":"Neuen, S. M. L. et al. Multipotent adult progenitor cells prevent functional impairment and improve development in inflammation driven detriment of preterm ovine lungs. Regen. Ther. 27, 207\u2013217 (2024).","journal-title":"Regen. Ther."},{"key":"5007_CR29","doi-asserted-by":"crossref","unstructured":"Park, H. Y. et al. Time dependent changes in the ovine neurovascular unit; a potential neuroprotective role of annexin A1 in neonatal hypoxic-ischemic encephalopathy. Int. J. Mol. Sci. 24, 5929 (2023).","DOI":"10.3390\/ijms24065929"},{"key":"5007_CR30","doi-asserted-by":"publisher","first-page":"e77377","DOI":"10.1371\/journal.pone.0077377","volume":"8","author":"M Castillo-Melendez","year":"2013","unstructured":"Castillo-Melendez, M. et al. Experimental modelling of the consequences of brief late gestation asphyxia on newborn lamb behaviour and brain structure. PLoS One 8, e77377 (2013).","journal-title":"PLoS One"},{"key":"5007_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000525150","volume":"44","author":"JK Mike","year":"2022","unstructured":"Mike, J. K. et al. Defining longer-term outcomes in an ovine model of moderate perinatal hypoxia-ischemia. Dev. Neurosci. 44, 277\u2013294 (2022).","journal-title":"Dev. Neurosci."},{"key":"5007_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","volume":"5","author":"B Th\u00e9baud","year":"2019","unstructured":"Th\u00e9baud, B. et al. Bronchopulmonary dysplasia. Nat. Rev. Dis. Prim. 5, 78 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"5007_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1159\/000540002","volume":"121","author":"W Durlak","year":"2024","unstructured":"Durlak, W. & Th\u00e9baud, B. BPD: latest strategies of prevention and treatment. Neonatology 121, 596\u2013607 (2024).","journal-title":"Neonatology"},{"key":"5007_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/pr.2017.249","volume":"83","author":"WS Park","year":"2018","unstructured":"Park, W. S., Ahn, S. Y., Sung, S. I., Ahn, J. Y. & Chang, Y. S. Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders. Pediatr. Res. 83, 214\u2013222 (2018).","journal-title":"Pediatr. Res."},{"key":"5007_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/stcltm\/szae060","volume":"13","author":"YS Chang","year":"2024","unstructured":"Chang, Y. S., Yang, M., Ahn, S. Y., Sung, S. I. & Park, W. S. Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders. Stem Cells Transl. Med. 13, 941\u2013948 (2024).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","volume":"51","author":"YS Chang","year":"2014","unstructured":"Chang, Y. S. et al. Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. 51, 391\u2013399 (2014).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"5007_CR37","first-page":"1","volume":"50","author":"SY Ahn","year":"2018","unstructured":"Ahn, S. Y. et al. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. Exp. Mol. Med 50, 1\u201312 (2018).","journal-title":"Exp. Mol. Med"},{"key":"5007_CR38","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang, Y. S. et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J. Pediatr. 164, 966\u2013972.e966 (2014).","journal-title":"J. Pediatr."},{"key":"5007_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","volume":"185","author":"SY Ahn","year":"2017","unstructured":"Ahn, S. Y., Chang, Y. S., Kim, J. H., Sung, S. I. & Park, W. S. Two-year follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia. J. Pediatr. 185, 49\u201354.e42 (2017).","journal-title":"J. Pediatr."},{"key":"5007_CR40","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/sctm.20-0330","volume":"10","author":"SY Ahn","year":"2021","unstructured":"Ahn, S. Y. et al. Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial. Stem Cells Transl. Med. 10, 1129\u20131137 (2021).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR41","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/thorax-2022-219622","volume":"78","author":"SY Ahn","year":"2023","unstructured":"Ahn, S. Y. et al. Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia. Thorax 78, 1105\u20131110 (2023).","journal-title":"Thorax"},{"key":"5007_CR42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/stcltm\/szae037","volume":"13","author":"N Kumar","year":"2024","unstructured":"Kumar, N., Bidkhori, H. R., Yawno, T., Lim, R. & Inocencio, I. M. Therapeutic potential of extracellular vesicles derived from human amniotic epithelial cells for perinatal cerebral and pulmonary injury. Stem Cells Transl. Med. 13, 711\u2013723 (2024).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13287-020-01951-w","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. & Lai, D. Application of human amniotic epithelial cells in regenerative medicine: a systematic review. Stem Cell Res. Ther. 11, 439 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR44","doi-asserted-by":"publisher","first-page":"e0173572","DOI":"10.1371\/journal.pone.0173572","volume":"12","author":"JM Melville","year":"2017","unstructured":"Melville, J. M. et al. Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs. PLoS One 12, e0173572 (2017).","journal-title":"PLoS One"},{"key":"5007_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-017-0689-9","volume":"8","author":"D Zhu","year":"2017","unstructured":"Zhu, D. et al. Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury. Stem Cell Res. Ther. 8, 257 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/sctm.18-0079","volume":"7","author":"R Lim","year":"2018","unstructured":"Lim, R. et al. First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study. Stem Cells Transl. Med. 7, 628\u2013635 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/sctm.19-0251","volume":"9","author":"A Malhotra","year":"2020","unstructured":"Malhotra, A., Lim, R., Mockler, J. C. & Wallace, E. M. Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia. Stem Cells Transl. Med. 9, 289\u2013294 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR48","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3727\/096368912X657657","volume":"22","author":"P Vosdoganes","year":"2013","unstructured":"Vosdoganes, P. et al. Human amnion epithelial cells repair established lung injury. Cell Transpl. 22, 1337\u20131349 (2013).","journal-title":"Cell Transpl."},{"key":"5007_CR49","doi-asserted-by":"crossref","unstructured":"Doktor, F. et al. Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential. Stem Cells Transl. Med. 14, szae095 (2025).","DOI":"10.1093\/stcltm\/szae095"},{"key":"5007_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373\u2013383 (2013).","journal-title":"J. Cell Biol."},{"key":"5007_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","volume":"36","author":"ER Abels","year":"2016","unstructured":"Abels, E. R. & Breakefield, X. O. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol. Neurobiol. 36, 301\u2013312 (2016).","journal-title":"Cell Mol. Neurobiol."},{"key":"5007_CR52","doi-asserted-by":"publisher","first-page":"153303382110412","DOI":"10.1177\/15330338211041203","volume":"20","author":"SP Kodam","year":"2021","unstructured":"Kodam, S. P. & Ullah, M. Diagnostic and therapeutic potential of extracellular vesicles. Technol. Cancer Res. Treat. 20, 15330338211041203 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"key":"5007_CR53","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.jcyt.2025.03.066","volume":"27","author":"MD Lastra","year":"2025","unstructured":"Lastra, M. D. et al. Human amnion epithelial cells and secretome drive the generation of tolerogenic macrophages and decidua-like Nk cells with lower proliferative capability and higher effector functions. Cytotherapy 27, S40\u2013S41 (2025).","journal-title":"Cytotherapy"},{"key":"5007_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13287-022-02874-4","volume":"13","author":"D Zhu","year":"2022","unstructured":"Zhu, D. et al. Assessing the impact of gestational age of donors on the efficacy of amniotic epithelial cell-derived extracellular vesicles in experimental bronchopulmonary dysplasia. Stem Cell Res. Ther. 13, 196 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR55","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jcyt.2019.03.581","volume":"21","author":"D Zhu","year":"2019","unstructured":"Zhu, D. et al. Human amnion cell-derived extracellular vesicles in the treatment of bronchopulmonary dysplasia and associated pulmonary hypertension. Cytotherapy 21, S15 (2019).","journal-title":"Cytotherapy"},{"key":"5007_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41572-022-00362-w","volume":"8","author":"A Zani","year":"2022","unstructured":"Zani, A. et al. Congenital diaphragmatic hernia. Nat. Rev. Dis. Prim. 8, 37 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"5007_CR57","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.ajpath.2016.07.006","volume":"186","author":"PK Donahoe","year":"2016","unstructured":"Donahoe, P. K., Longoni, M. & High, F. A. Polygenic causes of congenital diaphragmatic hernia produce common lung pathologies. Am. J. Pathol. 186, 2532\u20132543 (2016).","journal-title":"Am. J. Pathol."},{"key":"5007_CR58","doi-asserted-by":"crossref","unstructured":"Mous, D. S., Kool, H. M., Wijnen, R., Tibboel, D. & Rottier, R. J. Pulmonary vascular development in congenital diaphragmatic hernia. Eur. Respir. Rev. 27, 170104 (2018).","DOI":"10.1183\/16000617.0104-2017"},{"key":"5007_CR59","doi-asserted-by":"publisher","first-page":"151444","DOI":"10.1016\/j.sempedsurg.2024.151444","volume":"33","author":"M Jank","year":"2024","unstructured":"Jank, M., Doktor, F., Zani, A. & Keijzer, R. Cellular origins and translational approaches to congenital diaphragmatic hernia. Semin Pediatr. Surg. 33, 151444 (2024).","journal-title":"Semin Pediatr. Surg."},{"key":"5007_CR60","doi-asserted-by":"crossref","unstructured":"Pugnaloni, F. et al. Role of micrornas in congenital diaphragmatic hernia-associated pulmonary hypertension. Int. J. Mol. Sci. 24, 6656 (2023).","DOI":"10.3390\/ijms24076656"},{"key":"5007_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ppul.22739","volume":"48","author":"N Khoshgoo","year":"2013","unstructured":"Khoshgoo, N., Kholdebarin, R., Iwasiow, B. M. & Keijzer, R. Micrornas and lung development. Pediatr. Pulmonol. 48, 317\u2013323 (2013).","journal-title":"Pediatr. Pulmonol."},{"key":"5007_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2027030","volume":"385","author":"JA Deprest","year":"2021","unstructured":"Deprest, J. A. et al. Randomized trial of fetal surgery for severe left diaphragmatic hernia. N. Engl. J. Med. 385, 107\u2013118 (2021).","journal-title":"N. Engl. J. Med."},{"key":"5007_CR63","doi-asserted-by":"publisher","first-page":"101656","DOI":"10.1016\/j.siny.2025.101656","volume":"30","author":"A Dekirmendjian","year":"2025","unstructured":"Dekirmendjian, A., Doktor, F., Antounians, L. & Zani, A. Fetal therapies in congenital diaphragmatic hernia: a review of possibilities and practical challenges. Semin Fetal Neonatal Med. 30, 101656 (2025).","journal-title":"Semin Fetal Neonatal Med."},{"key":"5007_CR64","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pd.6120","volume":"42","author":"F Russo","year":"2022","unstructured":"Russo, F. et al. Antenatal management of congenital diaphragmatic hernia: what\u2019s next ? Prenat. Diagn. 42, 291\u2013300 (2022).","journal-title":"Prenat. Diagn."},{"key":"5007_CR65","doi-asserted-by":"crossref","unstructured":"Antounians, L. et al. Fetal lung underdevelopment is rescued by administration of amniotic fluid stem cell extracellular vesicles in rodents. Sci. Transl. Med. 13, eaax5941 (2021).","DOI":"10.1126\/scitranslmed.aax5941"},{"key":"5007_CR66","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/stcltm\/szac063","volume":"11","author":"K Khalaj","year":"2022","unstructured":"Khalaj, K. et al. Treatment with amniotic fluid stem cell extracellular vesicles promotes fetal lung branching and cell differentiation at canalicular and saccular stages in experimental pulmonary hypoplasia secondary to congenital diaphragmatic hernia. Stem Cells Transl. Med. 11, 1089\u20131102 (2022).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR67","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1164\/rccm.202109-2168OC","volume":"206","author":"K Khalaj","year":"2022","unstructured":"Khalaj, K., Antounians, L., Figueira, R. L., Post, M. & Zani, A. Autophagy is impaired in fetal hypoplastic lungs and rescued by administration of amniotic fluid stem cell extracellular vesicles. Am. J. Respir. Crit. Care Med. 206, 476\u2013487 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5007_CR68","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.jpedsurg.2024.02.029","volume":"59","author":"RL Figueira","year":"2024","unstructured":"Figueira, R. L. et al. Antenatal administration of extracellular vesicles derived from amniotic fluid stem cells improves lung function in neonatal rats with congenital diaphragmatic hernia. J. Pediatr. Surg. 59, 1771\u20131777 (2024).","journal-title":"J. Pediatr. Surg."},{"key":"5007_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn5405","volume":"10","author":"L Antounians","year":"2024","unstructured":"Antounians, L. et al. Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment. Sci. Adv. 10, eadn5405 (2024).","journal-title":"Sci. Adv."},{"key":"5007_CR70","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00383-023-05578-9","volume":"39","author":"M Blundell","year":"2023","unstructured":"Blundell, M. et al. Anti-inflammatory effects of antenatal administration of stem cell derived extracellular vesicles in the brain of rat fetuses with congenital diaphragmatic hernia. Pediatr. Surg. Int. 39, 291 (2023).","journal-title":"Pediatr. Surg. Int."},{"key":"5007_CR71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00383-023-05471-5","volume":"39","author":"L Antounians","year":"2023","unstructured":"Antounians, L. & Zani, A. Beyond the diaphragm and the lung: a multisystem approach to understanding congenital diaphragmatic hernia. Pediatr. Surg. Int. 39, 194 (2023).","journal-title":"Pediatr. Surg. Int."},{"key":"5007_CR72","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jpedsurg.2019.05.021","volume":"55","author":"L Montalva","year":"2020","unstructured":"Montalva, L., Raffler, G., Riccio, A., Lauriti, G. & Zani, A. Neurodevelopmental impairment in children with congenital diaphragmatic hernia: not an uncommon complication for survivors. J. Pediatr. Surg. 55, 625\u2013634 (2020).","journal-title":"J. Pediatr. Surg."},{"key":"5007_CR73","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/uog.7703","volume":"36","author":"T Van Mieghem","year":"2010","unstructured":"Van Mieghem, T. et al. Fetal cerebral blood flow velocities in congenital diaphragmatic hernia. Ultrasound Obstet. Gynecol. 36, 452\u2013457 (2010).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"5007_CR74","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/uog.21992","volume":"57","author":"KA Kosiv","year":"2021","unstructured":"Kosiv, K. A. et al. Fetal cerebrovascular impedance is reduced in left congenital diaphragmatic hernia. Ultrasound Obstet. Gynecol. 57, 386\u2013391 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"5007_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64412-x","volume":"14","author":"G Biouss","year":"2024","unstructured":"Biouss, G. et al. The brain of fetuses with congenital diaphragmatic hernia shows signs of hypoxic injury with loss of progenitor cells, neurons, and oligodendrocytes. Sci. Rep. 14, 13680 (2024).","journal-title":"Sci. Rep."},{"key":"5007_CR76","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/ejcts\/ezaa188","volume":"58","author":"N Alphonso","year":"2020","unstructured":"Alphonso, N. et al. Guidelines for the management of neonates and infants with hypoplastic left heart syndrome: the European Association for Cardio-Thoracic Surgery (Eacts) and the Association for European Paediatric and Congenital Cardiology (Aepc) Hypoplastic Left Heart Syndrome Guidelines Task Force. Eur. J. Cardiothorac. Surg. 58, 416\u2013499 (2020).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"5007_CR77","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.jacc.2025.04.028","volume":"85","author":"JW Gaynor","year":"2025","unstructured":"Gaynor, J. W. et al. Long-term survival and patient-reported outcomes after staged reconstructive surgery for hypoplastic left heart syndrome. J. Am. Coll. Cardiol. 85, 2386\u20132398 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"5007_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.878266","volume":"9","author":"AK Birla","year":"2022","unstructured":"Birla, A. K. et al. Current state of the art in hypoplastic left heart syndrome. Front Cardiovasc. Med. 9, 878266 (2022).","journal-title":"Front Cardiovasc. Med."},{"key":"5007_CR79","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.athoracsur.2009.10.035","volume":"89","author":"B Davies","year":"2010","unstructured":"Davies, B. et al. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training. Ann. Thorac. Surg. 89, 585\u2013593 (2010).","journal-title":"Ann. Thorac. Surg."},{"key":"5007_CR80","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.athoracsur.2015.04.130","volume":"100","author":"CP Brizard","year":"2015","unstructured":"Brizard, C. P. et al. Safety of intracoronary human cord blood stem cells in a lamb model of infant cardiopulmonary bypass. Ann. Thorac. Surg. 100, 1021\u20131029 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"5007_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5966\/sctm.2014-0195","volume":"4","author":"S Cantero Peral","year":"2015","unstructured":"Cantero Peral, S. et al. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Transl. Med. 4, 195\u2013206 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR82","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13287-025-04316-3","volume":"16","author":"C Gallego-Navarro","year":"2025","unstructured":"Gallego-Navarro, C. et al. Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections. Stem Cell Res. Ther. 16, 215 (2025).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR83","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/sctm.17-0069","volume":"6","author":"K Ballen","year":"2017","unstructured":"Ballen, K. Umbilical cord blood transplantation: challenges and future directions. Stem Cells Transl. Med. 6, 1312\u20131315 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"5007_CR84","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.exphem.2007.08.017","volume":"35","author":"C van de Ven","year":"2007","unstructured":"van de Ven, C., Collins, D., Bradley, M. B., Morris, E. & Cairo, M. S. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp. Hematol. 35, 1753\u20131765 (2007).","journal-title":"Exp. Hematol."},{"key":"5007_CR85","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/uog.26111","volume":"61","author":"A Dall\u2019Asta","year":"2023","unstructured":"Dall\u2019Asta, A., Melito, C., Morganelli, G., Lees, C. & Ghi, T. Determinants of placental insufficiency in fetal growth restriction. Ultrasound Obstet. Gynecol. 61, 152\u2013157 (2023).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"5007_CR86","doi-asserted-by":"publisher","first-page":"f108","DOI":"10.1136\/bmj.f108","volume":"346","author":"J Gardosi","year":"2013","unstructured":"Gardosi, J., Madurasinghe, V., Williams, M., Malik, A. & Francis, A. Maternal and fetal risk factors for stillbirth: population based study. Bmj 346, f108 (2013).","journal-title":"Bmj"},{"key":"5007_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2025.101628","volume":"7","author":"BR Piscopo","year":"2025","unstructured":"Piscopo, B. R. et al. The interplay between birth weight and intraventricular hemorrhage in very preterm neonates: a retrospective cohort study. Am. J. Obstet. Gynecol. MFM 7, 101628 (2025).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"5007_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fendo.2019.00055","volume":"10","author":"A Malhotra","year":"2019","unstructured":"Malhotra, A. et al. Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front Endocrinol. (Lausanne) 10, 55 (2019).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"5007_CR89","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1113\/JP271402","volume":"594","author":"SL Miller","year":"2016","unstructured":"Miller, S. L., Huppi, P. S. & Mallard, C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J. Physiol. 594, 807\u2013823 (2016).","journal-title":"J. Physiol."},{"key":"5007_CR90","doi-asserted-by":"publisher","first-page":"231842","DOI":"10.1155\/2010\/231842","volume":"2010","author":"C Ortigosa Rocha","year":"2010","unstructured":"Ortigosa Rocha, C., Bittar, R. E. & Zugaib, M. Neonatal outcomes of late-preterm birth associated or not with intrauterine growth restriction. Obstet. Gynecol. Int 2010, 231842 (2010).","journal-title":"Obstet. Gynecol. Int"},{"key":"5007_CR91","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/jp.2017.135","volume":"38","author":"A Sehgal","year":"2018","unstructured":"Sehgal, A. et al. Vascular aging and cardiac maladaptation in growth-restricted preterm infants. J. Perinatol. 38, 92\u201397 (2018).","journal-title":"J. Perinatol."},{"key":"5007_CR92","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000456542","volume":"39","author":"AK Alves de Alencar Rocha","year":"2017","unstructured":"Alves de Alencar Rocha, A. K. et al. Early- versus late-onset fetal growth restriction differentially affects the development of the fetal sheep brain. Dev. Neurosci. 39, 141\u2013155 (2017).","journal-title":"Dev. Neurosci."},{"key":"5007_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13330","volume":"35","author":"I Dudink","year":"2025","unstructured":"Dudink, I. et al. Fetal growth restriction adversely impacts trajectory of hippocampal neurodevelopment and function. Brain Pathol. 35, e13330 (2025).","journal-title":"Brain Pathol."},{"key":"5007_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1392-1","volume":"16","author":"JA Wixey","year":"2019","unstructured":"Wixey, J. A. et al. Neuropathology in intrauterine growth restricted newborn piglets is associated with glial activation and proinflammatory status in the brain. J. Neuroinflamm. 16, 5 (2019).","journal-title":"J. Neuroinflamm."},{"key":"5007_CR95","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13287-019-1526-0","volume":"11","author":"A Malhotra","year":"2020","unstructured":"Malhotra, A. et al. Neurovascular effects of umbilical cord blood-derived stem cells in growth-restricted newborn lambs. Stem Cell Res. Ther. 11, 17 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR96","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13287-023-03249-z","volume":"14","author":"A Bell","year":"2023","unstructured":"Bell, A. et al. Endothelial colony forming cell administration promotes neurovascular unit development in growth restricted and appropriately grown fetal lambs. Stem Cell Res. Ther. 14, 29 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"5007_CR97","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fneur.2014.00200","volume":"5","author":"J Li","year":"2014","unstructured":"Li, J., McDonald, C. A., Fahey, M. C., Jenkin, G. & Miller, S. L. Could cord blood cell therapy reduce preterm brain injury? Front Neurol. 5, 200 (2014).","journal-title":"Front Neurol."},{"key":"5007_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2016.06.017","volume":"283","author":"J Li","year":"2016","unstructured":"Li, J. et al. Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells. Exp. Neurol. 283, 179\u2013187 (2016).","journal-title":"Exp. Neurol."},{"key":"5007_CR99","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000490943","volume":"40","author":"MCB Paton","year":"2018","unstructured":"Paton, M. C. B. et al. Human umbilical cord blood therapy protects cerebral white matter from systemic LPS exposure in preterm fetal sheep. Dev. Neurosci. 40, 258\u2013270 (2018).","journal-title":"Dev. Neurosci."},{"key":"5007_CR100","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1113\/JP271104","volume":"594","author":"JD Aridas","year":"2016","unstructured":"Aridas, J. D. et al. Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb. J. Physiol. 594, 1421\u20131435 (2016).","journal-title":"J. Physiol."},{"key":"5007_CR101","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00441-012-1401-0","volume":"348","author":"K Rosenkranz","year":"2012","unstructured":"Rosenkranz, K. et al. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell Tissue Res. 348, 429\u2013438 (2012).","journal-title":"Cell Tissue Res."},{"key":"5007_CR102","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fnins.2019.01452","volume":"13","author":"AH Bell","year":"2019","unstructured":"Bell, A. H., Miller, S. L., Castillo-Melendez, M. & Malhotra, A. The neurovascular unit: effects of brain insults during the perinatal period. Front Neurosci. 13, 1452 (2019).","journal-title":"Front Neurosci."},{"key":"5007_CR103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41536-021-00185-5","volume":"6","author":"KK Chand","year":"2021","unstructured":"Chand, K. K. et al. Combination of human endothelial colony-forming cells and mesenchymal stromal cells exert neuroprotective effects in the growth-restricted newborn. NPJ Regen. Med. 6, 75 (2021).","journal-title":"NPJ Regen. Med"},{"key":"5007_CR104","unstructured":"Therapeutic Goods Administration. Australian Regulatory Guidelines for Biologicals (Argb), https:\/\/www.tga.gov.au\/products\/biologicals\/overview\/australian-regulatory-guidelines-biologicals-argb (2025)."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05007-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05007-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05007-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:01:50Z","timestamp":1778011310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05007-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":104,"alternative-id":["5007"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05007-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Authors acknowledge the use of a large language model to check on grammar and syntax of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI declaration"}}]}}